The data obtained clearly show that p53 protein expression is a risk factor in this regard, as 52.5% of patients with p53 expressing adenomas (regardless of the degree of dysplasia) had previous adenomas/carcinomas or coexisting adenomas. Here, TP53 is linked to carcinoma.